Moderna (NSDQ:MRNA) posted second-quarter results today that beat the overall consensus on Wall Street.
The Cambridge, Mass.–based company reported profits of $2.8 billion, or $6.46 per share, on sales of $4.4 billion for the three months ended June 30 for a sales growth of 6,398.51% compared with Q2 2020.
Get the full story on our sister site, Pharmaceutical Processing World.